Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05881564 · ClinicalTrials.gov registry record · NA

Blood Conservation in Patients (3.5-12kg) Undergoing Congenital Cardiac Surgery

A NA study of Congenital Heart Disease, sponsored by Augusta University.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT05881564 is a NA study of Congenital Heart Disease that is actively recruiting participants, run by Augusta University. The registered enrollment target is 150 participants, below the 472-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05881564, a NA study of Congenital Heart Disease, is actively recruiting participants, sponsored by Augusta University.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

To evaluate if there is any clinical difference in patients 3.5-12kg who undergo cardiac surgery with cardiopulmonary bypass that do and do not receive blood products as part of their procedure. The main hypothesis of the study is that the patients undergoing bloodless cardiac surgery will have decreased morbidity and mortality when compared to the cohort that did receive blood as well as a shorter ICU and hospital length of stay.

Conditions Studied

Congenital Heart Disease

Interventions

  • OTHER blood use for priming cardiopulmonary bypass circuit
  • OTHER clear prime for cardiopulmonary bypass

Study Locations (1)

Georgia

  • Children's Hospital of Georgia - Augusta

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2023-05-10
Est. Completion 2026-05-12
Phase NA

Sponsor

Augusta University

106 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05881564

The ClinicalTrials.gov registry entry for NCT05881564 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 472-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (68% lower). The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Congenital Heart Disease appearing as the primary indexed condition, and to 2 interventions - of which blood use for priming cardiopulmonary bypass circuit is the first listed.

NCT05881564 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT05881564 about?

NCT05881564 is a clinical study titled "Blood Conservation in Patients (3.5-12kg) Undergoing Congenital Cardiac Surgery". To evaluate if there is any clinical difference in patients 3.5-12kg who undergo cardiac surgery with cardiopulmonary bypass that do and do not receive blood products as part of their procedure. The main hypothesis of the study is that the patients undergoing bloodless cardiac surgery will have decr...

What is the current status of trial NCT05881564?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-05-10. Estimated completion is 2026-05-12.

What conditions does trial NCT05881564 study?

This clinical trial studies the following conditions: Congenital Heart Disease.

What interventions are being tested in trial NCT05881564?

The interventions under investigation include: blood use for priming cardiopulmonary bypass circuit (OTHER), clear prime for cardiopulmonary bypass (OTHER).

Who is sponsoring clinical trial NCT05881564?

This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05881564 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Congenital Heart Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Congenital Heart Disease

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.